Zimmer Biomet Holdings, Inc. Stock Xetra
Equities
ZIM
US98956P1021
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
113.3 EUR | +0.87% |
|
-.--% | -.--% |
Jul. 02 | Evercore ISI Adjusts Price Target on Zimmer Biomet Holdings to $115 From $130, Maintains In-Line Rating | MT |
Jul. 01 | Zimmer Biomet Shares Fall Following Piper Sandler Downgrade | MT |
Sales 2024 * | 7.76B 7.16B | Sales 2025 * | 8.12B 7.49B | Capitalization | 22.22B 20.5B |
---|---|---|---|---|---|
Net income 2024 * | 998M 921M | Net income 2025 * | 1.2B 1.1B | EV / Sales 2024 * | 3.42 x |
Net Debt 2024 * | 4.32B 3.99B | Net Debt 2025 * | 2.99B 2.76B | EV / Sales 2025 * | 3.11 x |
P/E ratio 2024 * |
22.2
x | P/E ratio 2025 * |
19.1
x | Employees | 18,000 |
Yield 2024 * |
0.89% | Yield 2025 * |
0.9% | Free-Float | 64.77% |
Latest transcript on Zimmer Biomet Holdings, Inc.
1 day | +0.87% |
![Extreme 95.4](/images/extremecours_fleche.png)
![Extreme 83.5](/images/extremecours_fleche.png)
![Extreme 83.5](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Ivan Tornos
CEO | Chief Executive Officer | 49 | 18-10-31 |
Suketu Upadhyay
DFI | Director of Finance/CFO | 55 | 19-06-30 |
Nitin Goyal
CTO | Chief Tech/Sci/R&D Officer | - | 21-06-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arthur Higgins
BRD | Director/Board Member | 68 | 06-12-31 |
Betsy Bernard
BRD | Director/Board Member | 68 | 08-12-31 |
Mick Farrell
BRD | Director/Board Member | 51 | 14-12-11 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.50% | 181B | |
-5.79% | 99.52B | |
-6.59% | 65.82B | |
-8.38% | 45.21B | |
+8.42% | 43.85B | |
+10.10% | 42.17B | |
+10.97% | 28.75B | |
+18.89% | 25.39B | |
-8.39% | 23.5B |
- Stock Market
- Equities
- ZBH Stock
- ZIM Stock